Header Logo

Shrish Kumar Pandey

TitleFellow,Postdoctoral Research
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentDepartment of Oncology Science
AddressBMSB 332
940 Stanton L Young Blvd
Oklahoma City OK 73104
Phone405/271-8001 ext 18001
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Temre MK, Devi B, Singh VK, Goel Y, Yadav S, Pandey SK, Kumar R, Kumar A, Singh SM. Molecular characterization of glutor-GLUT interaction and prediction of glutor's drug-likeness: implications for its utility as an antineoplastic agent. J Biomol Struct Dyn. 2022 Dec 26; 1-12. PMID: 36571488.
      Citations: 1     Fields:    Translation:Cells
    2. Temre MK, Yadav S, Goel Y, Pandey SK, Kumar A, Singh SM. Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity. Front Oncol. 2022; 12:925666. PMID: 35847943; PMCID: PMC9279700.
      Citations: 4     
    3. Goel Y, Yadav S, Pandey SK, Temre MK, Singh VK, Kumar A, Singh SM. Methyl Jasmonate Cytotoxicity and Chemosensitization of T Cell Lymphoma In Vitro Is Facilitated by HK 2, HIF-1a, and Hsp70: Implication of Altered Regulation of Cell Survival, pH Homeostasis, Mitochondrial Functions. Front Pharmacol. 2021; 12:628329. PMID: 33716751; PMCID: PMC7954117.
      Citations: 2     
    4. Goel Y, Yadav S, Pandey SK, Temre MK, Maurya BN, Verma A, Kumar A, Singh SM. Tumor Decelerating and Chemo-Potentiating Action of Methyl Jasmonate on a T Cell Lymphoma In Vivo: Role of Altered Regulation of Metabolism, Cell Survival, Drug Resistance, and Intratumoral Blood Flow. Front Oncol. 2021; 11:619351. PMID: 33718176; PMCID: PMC7947686.
      Citations: 8     
    5. Yadav S, Pandey SK, Goel Y, Temre MK, Singh SM. Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate. Front Pharmacol. 2019; 10:728. PMID: 31333455; PMCID: PMC6620530.
      Citations: 6     
    6. Yadav S, Pandey SK, Goel Y, Temre MK, Singh SM. Antimetabolic Agent 3-Bromopyruvate Exerts Myelopotentiating Action in a Murine Host Bearing a Progressively Growing Ascitic Thymoma. Immunol Invest. 2020 May; 49(4):425-442. PMID: 31264492.
      Citations: 2     Fields:    Translation:AnimalsCells
    7. Pandey SK, Yadav S, Goel Y, Temre MK, Singh VK, Singh SM. Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics. J Theor Biol. 2019 03 21; 465:117-125. PMID: 30653975.
      Citations: 3     Fields:    Translation:HumansCells
    8. Pandey SK, Yadav S, Temre MK, Singh SM. Tracking acetate through a journey of living world: Evolution as alternative cellular fuel with potential for application in cancer therapeutics. Life Sci. 2018 Dec 15; 215:86-95. PMID: 30408472.
      Citations: 4     Fields:    Translation:HumansAnimals
    9. Pandey SK, Yadav S, Goel Y, Singh SM. Cytotoxic action of acetate on tumor cells of thymic origin: Role of MCT-1, pH homeostasis and altered cell survival regulation. Biochimie. 2019 Feb; 157:1-9. PMID: 30391286.
      Citations: 4     Fields:    Translation:AnimalsCells
    10. Yadav S, Pandey SK, Goel Y, Kujur PK, Maurya BN, Verma A, Kumar A, Singh RP, Singh SM. Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: Implication of niche dependent differential roles of macrophages. Biomed Pharmacother. 2018 Mar; 99:970-985. PMID: 29689702.
      Citations: 9     Fields:    Translation:AnimalsCells
    11. Yadav S, Kujur PK, Pandey SK, Goel Y, Maurya BN, Verma A, Kumar A, Singh RP, Singh SM. Antitumor action of 3-bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria-dependent tumor cell death. Toxicol Appl Pharmacol. 2018 01 15; 339:52-64. PMID: 29221953.
      Citations: 5     Fields:    Translation:AnimalsCells
    12. Yadav S, Pandey SK, Singh VK, Goel Y, Kumar A, Singh SM. Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies. PLoS One. 2017; 12(5):e0176403. PMID: 28463978; PMCID: PMC5413015.
      Citations: 23     Fields:    Translation:HumansCells
    13. Yadav S, Pandey SK, Kumar A, Kujur PK, Singh RP, Singh SM. Antitumor and chemosensitizing action of 3-bromopyruvate: Implication of deregulated metabolism. Chem Biol Interact. 2017 May 25; 270:73-89. PMID: 28433571.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    Pandey's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (73)
    Similar People (60)
    Same Department Expand Description